IBM Forecast, price target & analysts
IBM Target price 2026 - Analyst rating & recommendation
IBM Classifications & Recommendation:
IBM Price Target
| Target Price | $306.00 |
| Price | $294.97 |
| Potential | 3.74% |
| Number of Estimates | 24 |
| 24 Analysts have issued a price target IBM 2027 . The average IBM target price is $306.00. This is 3.74% higher than the current stock price. The highest price target is $378.00 28.15% , the lowest is $199.98 32.20% . | |
| A rating was issued by 27 analysts: 13 Analysts recommend IBM to buy, 11 to hold and 3 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the IBM stock has an average upside potential 2027 of 3.74% . Most analysts recommend the IBM stock at Purchase. |
Sales and Margin forecast 2025, 2026 to 2032
24 Analysts have issued a sales forecast IBM 2025 . The average IBM sales estimate is $67.7b . This is 3.56% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $70.9b 8.42% , the lowest is $65.5b 0.13% .
This results in the following potential growth metrics:
Revenue Estimates
| 2024 | $62.8b | 1.44% |
|---|---|---|
| 2025 | $67.7b | 7.93% |
| 2026 | $70.8b | 4.58% |
| 2027 | $73.9b | 4.31% |
| 2028 | $77.8b | 5.30% |
| 2029 | $81.4b | 4.58% |
| 2030 | $85.5b | 5.14% |
| 2031 | $90.6b | 5.93% |
| 2032 | $95.4b | 5.22% |
16 Analysts have issued an IBM EBITDA forecast 2025. The average IBM EBITDA estimate is $19.0b . This is 28.91% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $20.2b 37.15% , the lowest is $17.8b 20.68% .
This results in the following potential growth metrics and future EBITDA Margins:
EBITDA Estimates
| 2024 | $10.1b | 3.71% |
|---|---|---|
| 2025 | $19.0b | 87.41% |
| 2026 | $20.0b | 5.08% |
| 2027 | $20.9b | 4.42% |
| 2028 | $21.9b | 4.89% |
| 2029 | $24.2b | 10.55% |
| 2030 | $25.9b | 7.08% |
| 2031 | $28.4b | 9.53% |
| 2032 | $30.6b | 7.82% |
EBITDA Margin
| 2024 | 16.17% | 2.23% |
|---|---|---|
| 2025 | 28.08% | 73.62% |
| 2026 | 28.22% | 0.50% |
| 2027 | 28.25% | 0.11% |
| 2028 | 28.14% | 0.39% |
| 2029 | 29.74% | 5.69% |
| 2030 | 30.29% | 1.85% |
| 2031 | 31.32% | 3.40% |
| 2032 | 32.09% | 2.46% |
25 IBM Analysts have issued a net profit forecast 2025. The average IBM net profit estimate is $10.7b . This is 35.21% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $11.2b 42.25% , the lowest is $10.1b 28.04% .
This results in the following potential growth metrics and future Net Margins:
Net Profit Estimates
| 2024 | $6.0b | 19.71% |
|---|---|---|
| 2025 | $10.7b | 77.50% |
| 2026 | $11.5b | 7.31% |
| 2027 | $12.2b | 5.99% |
| 2028 | $12.4b | 1.66% |
| 2029 | $12.9b | 4.49% |
| 2030 | $14.2b | 9.76% |
| 2031 | $16.2b | 14.40% |
| 2032 | $17.8b | 9.92% |
Net Margin
| 2024 | 9.60% | 20.86% |
|---|---|---|
| 2025 | 15.78% | 64.41% |
| 2026 | 16.20% | 2.66% |
| 2027 | 16.46% | 1.60% |
| 2028 | 15.89% | 3.46% |
| 2029 | 15.88% | 0.06% |
| 2030 | 16.57% | 4.35% |
| 2031 | 17.90% | 8.03% |
| 2032 | 18.70% | 4.47% |
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032
25 Analysts have issued a IBM forecast for earnings per share. The average IBM EPS is $11.48 . This is 37.82% higher than earnings per share in the financial year 2024. The highest EPS forecast is $12.08 45.02% , the lowest is $10.87 30.49% .
This results in the following potential growth metrics and future valuations:
Earnings Per Share
| 2024 | $6.42 | 21.03% |
|---|---|---|
| 2025 | $11.48 | 78.82% |
| 2026 | $12.32 | 7.32% |
| 2027 | $13.05 | 5.93% |
| 2028 | $13.27 | 1.69% |
| 2029 | $13.87 | 4.52% |
| 2030 | $15.22 | 9.73% |
| 2031 | $17.41 | 14.39% |
| 2032 | $19.14 | 9.94% |
P/E ratio
| Current | 35.41 | 1.63% |
|---|---|---|
| 2025 | 25.70 | 27.42% |
| 2026 | 23.95 | 6.81% |
| 2027 | 22.60 | 5.64% |
| 2028 | 22.23 | 1.64% |
| 2029 | 21.27 | 4.32% |
| 2030 | 19.38 | 8.89% |
| 2031 | 16.94 | 12.59% |
| 2032 | 15.41 | 9.03% |
Based on analysts' sales estimates for 2025, the IBM stock is valued at an EV/Sales of 4.78 and an P/S ratio of 4.07 .
This results in the following potential growth metrics and future valuations:
EV/Sales
| Current | 4.95 | 26.28% |
|---|---|---|
| 2025 | 4.78 | 3.37% |
| 2026 | 4.57 | 4.38% |
| 2027 | 4.38 | 4.14% |
| 2028 | 4.16 | 5.03% |
| 2029 | 3.98 | 4.38% |
| 2030 | 3.79 | 4.89% |
| 2031 | 3.58 | 5.60% |
| 2032 | 3.40 | 4.97% |
P/S ratio
| Current | 4.22 | 28.50% |
|---|---|---|
| 2025 | 4.07 | 3.43% |
| 2026 | 3.89 | 4.38% |
| 2027 | 3.73 | 4.13% |
| 2028 | 3.54 | 5.03% |
| 2029 | 3.39 | 4.38% |
| 2030 | 3.22 | 4.89% |
| 2031 | 3.04 | 5.60% |
| 2032 | 2.89 | 4.96% |
Current IBM Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Stifel |
Buy
➜
Buy
|
Unchanged | Dec 09 2025 |
| Oppenheimer |
➜
Outperform
|
Initiated | Nov 21 2025 |
| RBC Capital |
Outperform
➜
Outperform
|
Unchanged | Oct 23 2025 |
| Morgan Stanley |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Oct 23 2025 |
| Stifel |
Buy
➜
Buy
|
Unchanged | Oct 23 2025 |
| B of A Securities |
Buy
➜
Buy
|
Unchanged | Oct 23 2025 |
| BMO Capital |
Market Perform
➜
Market Perform
|
Unchanged | Oct 23 2025 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
Stifel:
Buy
➜
Buy
|
Dec 09 2025 |
|
Initiated
Oppenheimer:
➜
Outperform
|
Nov 21 2025 |
|
Unchanged
RBC Capital:
Outperform
➜
Outperform
|
Oct 23 2025 |
|
Unchanged
Morgan Stanley:
Equal-Weight
➜
Equal-Weight
|
Oct 23 2025 |
|
Unchanged
Stifel:
Buy
➜
Buy
|
Oct 23 2025 |
|
Unchanged
B of A Securities:
Buy
➜
Buy
|
Oct 23 2025 |
|
Unchanged
BMO Capital:
Market Perform
➜
Market Perform
|
Oct 23 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
